🇺🇸 FDA
Patent

US 7662814

4-aminothieno[2,3-d]pyrimidine-6-carbonitrile derivatives as PDE7 inhibitors

granted A61PA61P1/04A61P11/00

Quick answer

US patent 7662814 (4-aminothieno[2,3-d]pyrimidine-6-carbonitrile derivatives as PDE7 inhibitors) held by Laboratories Almirall, S.A. expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Laboratories Almirall, S.A.
Grant date
Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P1/04, A61P11/00, A61P11/06, A61P17/00